Cargando…
Alzheimer's and Parkinson's disease therapies in the clinic
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent neurodegenerative diseases, affecting millions and costing billions each year in the United States alone. Despite tremendous progress in developing therapeutics that manage the symptoms of these two diseases, the...
Autores principales: | Chopade, Puja, Chopade, Neha, Zhao, Zongmin, Mitragotri, Samir, Liao, Rick, Chandran Suja, Vineeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842041/ https://www.ncbi.nlm.nih.gov/pubmed/36684083 http://dx.doi.org/10.1002/btm2.10367 |
Ejemplares similares
-
Red Blood Cell Anchoring Enables Targeted Transduction and Re‐Administration of AAV‐Mediated Gene Therapy
por: Zhao, Zongmin, et al.
Publicado: (2022) -
Viral vector‐based gene therapies in the clinic
por: Zhao, Zongmin, et al.
Publicado: (2021) -
Digital therapeutics in the clinic
por: Phan, Philana, et al.
Publicado: (2023) -
RNA therapeutics in the clinic
por: Curreri, Alexander, et al.
Publicado: (2022) -
A backpack-based myeloid cell therapy for multiple sclerosis
por: Kapate, Neha, et al.
Publicado: (2023)